| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/2007 | EP1150695B1 Herbal supplement for increased muscle strength and endurance for athletes |
| 02/28/2007 | EP1150671B1 Use of pyrethroid compounds to promote hair growth |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | EP1096937B9 Sustained release ranolazine formulations |
| 02/28/2007 | EP1096926B1 Methods and compounds for treating depression |
| 02/28/2007 | EP1091928B1 Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
| 02/28/2007 | EP1083915B1 Compositions comprising molybdenum for enhancing protein anabolism and detoxification |
| 02/28/2007 | EP1079802B1 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention |
| 02/28/2007 | EP1073737B1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/28/2007 | EP1033979B9 Combination of cyp2a enzyme inhibitors and nicotine and their therapeutic use |
| 02/28/2007 | EP1025077B1 Novel aryloxy-alkyl-dialkylamines |
| 02/28/2007 | EP0799034B1 Use of aromatic or branched chain amino acids for the treatment of movement disorders |
| 02/28/2007 | CN1922332A Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 02/28/2007 | CN1922321A Oligonucleotide and the use thereof for modulating an isoform c beta-1 protein-kinase in the form of a skin depigmentation agent |
| 02/28/2007 | CN1922320A Antisense compounds targeted to connexins and methods of use thereof |
| 02/28/2007 | CN1922196A Crystalline forms of a pharmaceutical compound |
| 02/28/2007 | CN1922191A Crystal of oxacephem |
| 02/28/2007 | CN1922190A 3-pyridinium methylcephem compound |
| 02/28/2007 | CN1922189A Spirocyclic cyclohexane derivatives with affinity for the ORL1-receptor |
| 02/28/2007 | CN1922188A Pharmacologically acceptable salts of clopidogrel |
| 02/28/2007 | CN1922187A Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12] urils |
| 02/28/2007 | CN1922186A Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands |
| 02/28/2007 | CN1922185A Pyrazolotriazines as kinase inhibitors |
| 02/28/2007 | CN1922184A 7H-pyrrolopyrimidine derivatives |
| 02/28/2007 | CN1922183A Nitrogenous fused heteroaromatic ring derivative |
| 02/28/2007 | CN1922182A Pyrrolotriazine compounds as kinase inhibitors |
| 02/28/2007 | CN1922181A Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives |
| 02/28/2007 | CN1922180A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 02/28/2007 | CN1922179A Crystalline forms of valacyclovir hydrochloride |
| 02/28/2007 | CN1922178A Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds |
| 02/28/2007 | CN1922177A Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors |
| 02/28/2007 | CN1922176A Condensed bicycle heterocycle substituted quinuclidine derivant |
| 02/28/2007 | CN1922175A Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| 02/28/2007 | CN1922174A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 02/28/2007 | CN1922172A Substituted heterocyclic compounds and uses thereof |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922170A Novel hydroxy-6-heroarylphenanthridines and their use as pde4 inhibitors |
| 02/28/2007 | CN1922169A Spirocyclic heterocyclic derivatives and methods of their use |
| 02/28/2007 | CN1922162A Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 02/28/2007 | CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1922159A Benzamide derivatives and their use as glucokinase activating agents |
| 02/28/2007 | CN1922158A Isothiourea derivatives |
| 02/28/2007 | CN1922157A Benzo[d]isoxazol-3-ol daao inhibitors |
| 02/28/2007 | CN1922156A Substituted triazoles as sodium channel blockers |
| 02/28/2007 | CN1922155A Novel sulfone amide derivative |
| 02/28/2007 | CN1922151A Substituted azole derivatives, compositions, and methods of use |
| 02/28/2007 | CN1922150A Indazole derivatives and pharmaceutical compositions containing them |
| 02/28/2007 | CN1922149A Pyrrole and pyrazole daao inhibitors |
| 02/28/2007 | CN1922148A Pyrazole derivatives as protein kinase modulators |
| 02/28/2007 | CN1922147A Novel style heterocyclic compound as insulin-like growth factors first type acceptor inhibitor |
| 02/28/2007 | CN1922146A Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| 02/28/2007 | CN1922144A Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 02/28/2007 | CN1922143A Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents |
| 02/28/2007 | CN1922141A Novel heterocyclic compound |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1922137A Protease inhibitors |
| 02/28/2007 | CN1922133A Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof |
| 02/28/2007 | CN1921891A Growth factor-binding compounds and methods of use |
| 02/28/2007 | CN1921888A Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same |
| 02/28/2007 | CN1921885A Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
| 02/28/2007 | CN1921881A Use of hydroxylated amino acids for treating diabetes |
| 02/28/2007 | CN1921869A Lipase activity inhibitor containing high-molecular weight polyphenol fraction, tea extract and process for producing the same |
| 02/28/2007 | CN1921868A Topical otic compositions and methods of topical treatment of prevention of otic infections |
| 02/28/2007 | CN1921867A Nucleoside phosphonate derivatives useful in the treatment of HIV infections |
| 02/28/2007 | CN1921866A Therapy using a combination of raloxifene and alendronate |
| 02/28/2007 | CN1921865A Use of meloxicam for the treatment of respiratory diseases in pigs |
| 02/28/2007 | CN1921864A Treatment of malignant gliomas with TGF-beta inhibitors |
| 02/28/2007 | CN1921863A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 02/28/2007 | CN1921862A Immunostimulant composition comprising at least one TOLL-like receptor 7 or TOLL-like receptor 8 agonist and a TOLL-like receptor 4 agonist |
| 02/28/2007 | CN1921861A Directly compressible pharmaceutical composition for the oral administration of cci-779 |
| 02/28/2007 | CN1921860A Hyperlipemia therapeutic agent |
| 02/28/2007 | CN1921859A Indole derivatives for the treatment of bone diseases |
| 02/28/2007 | CN1921858A Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors |
| 02/28/2007 | CN1921857A Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases |
| 02/28/2007 | CN1921856A Dpp-iv inhibitors for treating neurodegeneration and cognitive disorders |
| 02/28/2007 | CN1921855A KV1.5-blocker for the selective increase of atrial contractility and treatment of cardiac insufficiency |
| 02/28/2007 | CN1921854A Heterocyclic GABAA subtype selective receptor modulators |
| 02/28/2007 | CN1921853A Preventive or therapeutic agents for severe diabetic retinopathy |
| 02/28/2007 | CN1921852A Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the b-type receptor of interleukin 8 and/or to a pacap type 1 receptor |
| 02/28/2007 | CN1921851A Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation |
| 02/28/2007 | CN1921850A Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous vascularisation disorder |
| 02/28/2007 | CN1921849A Combination treatment of obesity involving 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity and lipase inhibitors |
| 02/28/2007 | CN1921848A Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 02/28/2007 | CN1921847A 氨基醇化合物 Amino alcohol compound |
| 02/28/2007 | CN1921846A Combinatorial therapy with an acetylcholinesterase inhibitor and (3AR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
| 02/28/2007 | CN1921845A Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation |
| 02/28/2007 | CN1921844A Use of cholinesterase inhibitors for treating vascular depression |
| 02/28/2007 | CN1921843A Retinoic acid-containing remedy for diabetes |
| 02/28/2007 | CN1921842A Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite |
| 02/28/2007 | CN1921841A Amines and amides for the treatment of diseases |
| 02/28/2007 | CN1921840A Multilayer tablet |
| 02/28/2007 | CN1921839A Stable sustained-release oral dosage forms of gabapentin and process for preparation thereof |
| 02/28/2007 | CN1921838A Extended release pharmaceutical compositions of divalproex sodium |
| 02/28/2007 | CN1921837A Method of preparing low-crystallinity oltipraz or amorphous oltipraz |
| 02/28/2007 | CN1921835A Stable pharmaceutical solution formulation for pressurized metered dose inhalers |
| 02/28/2007 | CN1921834A Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
| 02/28/2007 | CN1921833A Alginate viscoelastic composition, method of use and package |
| 02/28/2007 | CN1921832A Dissolvable film and method of manufacture |
| 02/28/2007 | CN1921830A Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 02/28/2007 | CN1921829A 贴片 Patch |